| INSILICO MEDICINE |
| China |
| Gesundheit |
| KYG4790P1037 / A41XT7 |
| O15 (Frankfurt) |
| FRA:O15, ETR:O15, O15:GR |
| - |
| https://insilico.com/ |
|
InSilico Medicine Cayman TopCo is an artificial intelligence-based biotechnology company focused on drug discovery and development. It leverages generative AI through its Pharma.AI platform, an end-to-end software and automation solution that enhance..
>Volltext.. |
| 3172.92 Mio. EUR |
| 2795.13 Mio. EUR |
| 48.54 Mio. EUR |
| -47.66 Mio. EUR |
| -304.21 Mio. EUR |
| - |
| 5.14 Mio. EUR |
| 338.96 Mio. EUR |
| - |
| 13.2 |
| -34.59% |
| -1967.91% |
| - |
| - |
| - |
| - |
| INSILICO |
| 26.05.26 |
|